Literature DB >> 27114749

Application of the Prague C and M criteria for endoscopic description of columnar-lined esophagus in South Korea.

Jung Wan Choe1, Young Choon Kim1, Moon Kyung Joo1, Hyo Jung Kim1, Beom Jae Lee1, Ji Hoon Kim1, Jong Eun Yeon1, Jong-Jae Park1, Jae Seon Kim1, Kwan Soo Byun1, Young-Tae Bak1.   

Abstract

AIM: To ascertain whether the Prague circumferential (C) length and maximal (M) length criteria for grading the extent of Barrett's esophagus can be applied prior to its widespread application in South Korea.
METHODS: Two hundred and thirteen consecutive cases with endoscopic columnar-lined esophagus (CLE) were included and classified according to the Prague C and M criteria.
RESULTS: Of 213 cases with CLE, the distribution of maximum CLE lengths was: 0.5-0.9 cm in 99 cases (46.5%); 1.0-1.4 cm in 63 cases (29.6%); 1.5-1.9 cm in 15 cases (7.0%); 2.0-2.4 cm in 14 cases (6.6%); 2.5-2.9 cm in 1 case (0.5%); and 7.0 cm in 1 case (0.5%). Twenty cases (9.4%) had columnar islands alone. Two hundred and eight cases (97.7%) lacked the circumferential CLE component (C0Mx). Columnar islands were found in 70 cases (32.9%), of which 20 cases (9.4%) had columnar islands alone.
CONCLUSION: In regions where most CLE patients display short or ultrashort tongue-like appearance, more detailed descriptions of CLE's in < 1.0 cm lengths and columnar islands, as well as avoidance of repeating the prefix "C0" need to be considered in parallel with the widespread application of the Prague system in South Korea.

Entities:  

Keywords:  Barrett’s esophagus; Columnar-lined esophagus; Endoscopy; Prague criteria

Year:  2016        PMID: 27114749      PMCID: PMC4835663          DOI: 10.4253/wjge.v8.i8.357

Source DB:  PubMed          Journal:  World J Gastrointest Endosc


  33 in total

1.  Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus.

Authors:  Kenneth K Wang; Richard E Sampliner
Journal:  Am J Gastroenterol       Date:  2008-03       Impact factor: 10.864

2.  Diagnostic inconsistencies in Barrett's esophagus. Department of Veterans Affairs Gastroesophageal Reflux Study Group.

Authors:  S L Kim; J P Waring; S J Spechler; R E Sampliner; W G Doos; W F Krol; W O Williford
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

3.  Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries.

Authors:  A A Botterweck; L J Schouten; A Volovics; E Dorant; P A van Den Brandt
Journal:  Int J Epidemiol       Date:  2000-08       Impact factor: 7.196

4.  The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria.

Authors:  Prateek Sharma; John Dent; David Armstrong; Jacques J G H M Bergman; Liebwin Gossner; Yoshio Hoshihara; Janusz A Jankowski; Ola Junghard; Lars Lundell; Guido N J Tytgat; Michael Vieth
Journal:  Gastroenterology       Date:  2006-08-16       Impact factor: 22.682

5.  Barrett's esophagus: development of dysplasia and adenocarcinoma.

Authors:  W Hameeteman; G N Tytgat; H J Houthoff; J G van den Tweel
Journal:  Gastroenterology       Date:  1989-05       Impact factor: 22.682

6.  Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease.

Authors:  C Winters; T J Spurling; S J Chobanian; D J Curtis; R L Esposito; J F Hacker; D A Johnson; D F Cruess; J D Cotelingam; M S Gurney
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

7.  [The prevalence of esophageal disorders in the subjects examined for health screening].

Authors:  Seung Suk Yoo; Won Hyun Lee; Jong Ha; Sun Pil Choi; Hyun Jin Kim; Tae Hyo Kim; Ok Jae Lee
Journal:  Korean J Gastroenterol       Date:  2007-11

8.  Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study.

Authors:  Modh Said Rosaida; Khean-Lee Goh
Journal:  Eur J Gastroenterol Hepatol       Date:  2004-05       Impact factor: 2.566

9.  Adenocarcinoma in Barrett's oesophagus: an overrated risk.

Authors:  A H Van der Veen; J Dees; J D Blankensteijn; M Van Blankenstein
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

Review 10.  When and how to grade Barrett's columnar metaplasia: the Prague system.

Authors:  Oksana Anand; Sachin Wani; Prateek Sharma
Journal:  Best Pract Res Clin Gastroenterol       Date:  2008       Impact factor: 3.043

View more
  1 in total

Review 1.  Evolving management of metaplasia and dysplasia in Barrett's epithelium.

Authors:  Richard P T Evans; Moustafa Mabrouk Mourad; Simon G Fisher; Simon R Bramhall
Journal:  World J Gastroenterol       Date:  2016-12-21       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.